Skip to content

Clinical Outcome of Liberal or Restrictive Strategy in Correction of Hypocalcemia in Septic Shock: The COLORIS Randomized controlled trial

Clinical Outcome of Liberal or Restrictive Strategy in Correction of Hypocalcemia in Septic Shock: The COLORIS Randomized controlled trial

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260225001
Enrollment
392
Registered
2026-02-25
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

How do restrictive versus liberal strategies of intravenous calcium supplementation affect time of shock resolution and hemodynamic parameters in septic shock patients? hypocalcemia, sepsis, septic shock, time of shock resolution, ionized calcium

Interventions

In the restrictive strategy group, intravenous calcium gluconate will be administered to each patient once their blood gas results confirm that the ionized calcium level is 0.9 mmol/L or lower. The tr
Experimental Drug,Experimental Drug
Restrictive group,Liberal group

Sponsors

Faculty of Medicine, Khon Kaen University.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 years or older. 2. Patients who meet the clinical criteria for septic shock, defined below, and already monitored with invasive blood pressure monitoring. 3. Patients who have asymptomatic hypocalcemia, which is defined as a single measurement of ionized calcium levels below 1.15 mmol/L from arterial blood gas analysis.

Exclusion criteria

Exclusion criteria: 1. Patients previously diagnosed with parathyroid disorders: hyperparathyroidism or previously known parathyroid hormone level more than 5 times the upper normal limit (325 pg/mL) 2. Patients who are currently receiving continuous calcium infusions or total parenteral nutrition 3. Patients who used bisphosphonate last year before enrollment. 4. Patients diagnosed with chronic kidney disease (CKD) stage 4 or 5, or those who require renal replacement therapy 5. Patients are diagnosed with terminal illness or palliative care, with a prognosis of less than six months. Or A Do Not Resuscitate (DNR) order has also been prescribed by the patient's wishes 6. Pregnancy (every woman who was enrolled in the study was checked using urine pregnancy tests) 7. Patients who refuse to engage in the study or cannot identify legally authorized representatives (LAR) within 24 hours 8. Patients who meet criteria for septic shock more than 24 hours. 9. Patients who have cardiac arrest within 24 hours

Design outcomes

Primary

MeasureTime frame
Time of shock resolution at resolving of shock hour

Secondary

MeasureTime frame
Hemodynamic parameters (mean arterial pressure) at 30, 60, 90 minutes, post calcium infusion at 30, 60, 90 minutes, post calcium infusion mmHg,Difference of ionized calcium concentration at each monitoring Delta ionized calcium every 6 hours Delta ionized calcium every 6 hours,Lactate clearance, post calcium infusion every 6 hours Lactate clearance,Difference of Sequential Organ Failure Assessment at 72 hours after randomization at 72 hours after randomization Delta Sequential Organ Failure Assessment,A new organ failure in the first week, defined as the number and the severity of organ dysfunction 1 week after randomization Number of event ,Organ failure-free day on day 28 after randomization free day ,Renal replacement therapy-free day on day 28 after randomization free day ,28-day mortality after randomization 28 day after randomization mortality,Length of Intensive Care Unit stay after Intensive Care Unit discharge or death day,Vasopressor-free day on day 28 after randomization free day ,Ventilator-free day on day 28 after randomization free day ,Cumulative calcium administration (72 hours after randomization) Cumulative calcium in ml, mEq

Countries

Thailand

Contacts

Public ContactSupawat Wittayapairoj

Faculty of Medicine, Khon Kaen University

supawit@kku.ac.th0644155522

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026